Hot Topics in NASH

Learn what’s new in NASH. Hear from leading experts in endocrinology and gastroenterology as they discuss the hottest topics surrounding diagnosing and treating patients with NASH/NAFLD.
Kenneth Cusi, MD, FACP, FACE
Program Director
Stephen A. Harrison, MD, COL (Ret.), FAASLD

Real-World Practice Implications

Expert faculty explain how to interpret endpoints used in NASH studies so you can evaluate emerging treatments.

Kenneth Cusi, MD, FACP, FACE
Program Director
Stephen A. Harrison, MD, COL (Ret.), FAASLD
Released: March 26, 2019

Expert hepatologist explains how to interpret endpoints used in NASH studies so you can evaluate emerging treatments.

Stephen A. Harrison, MD, COL (Ret.), FAASLD Released: March 29, 2019

Expert endocrinologist explains how to interpret endpoints used in NASH studies so you can evaluate emerging treatments.

Kenneth Cusi, MD, FACP, FACE
Program Director
Released: March 29, 2019
Provided by the American Gastroenterological Association

American Gastroenterological Association (AGA)
4930 Del Ray Avenue
Bethesda, MD 20814
Phone: (301) 654-2055
Fax: (301) 654-5920
Email: member@gastro.org

Produced in collaboration with
Endocrine Society Logo
Supported by educational grants from
Gilead Sciences, Inc.
Intercept Pharmaceuticals, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue